Basics Foghorn Therapeutics Inc. IPO Date: October 23, 2020 Sector: Healthcare Industry: Biotech Market Cap: $246.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 4.05% Avg Daily Range (30 D): $0.16 | 3.77% Avg Daily Range (90 D): $0.17 | 3.57% Institutional Daily Volume Avg Daily Volume: .11M Avg Daily Volume (30 D): .19M Avg Daily Volume (90 D): .14M Trade Size Avg Trade Size (Sh.): 82 Avg Trade Size (Sh.) (30 D): 81 Avg Trade Size (Sh.) (90 D): 83 Institutional Trades Total Inst.Trades: 83 Avg Inst. Trade: $1.53M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $.57M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.61M Avg Closing Trade (30 D): $.59M Avg Closing Trade (90 D): $.59M Avg Closing Volume: 219.86K     News Nov 17, 2025 @ 11:00 AM 4DMT Appoints Kristian Humer as Chief Financial Of... Source: 4D Molecular Therapeutics Aug 27, 2025 @ 11:00 AM Foghorn Therapeutics to Participate in Three Upcom... Source: Karin Hellsvik Aug 5, 2025 @ 11:00 AM Foghorn Therapeutics Provides Second Quarter 2025 ... Source: Foghorn Therapeutics Inc. May 1, 2025 @ 11:00 AM Foghorn Therapeutics Appoints Neil Gallagher and S... Source: N/A Apr 15, 2025 @ 11:00 AM Foghorn Therapeutics to Host Virtual Investor Even... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.25 $-.28 $-.3 Diluted EPS $-.25 $-.28 $-.3 Revenue $ 8.15M $ 7.56M $ 5.95M Gross Profit $ $ $ Net Income / Loss $ -15.85M $ -17.94M $ -18.83M Operating Income / Loss $ -18.5M $ -21.1M $ -22.91M Cost of Revenue $ $ $ Net Cash Flow $ 16.76M $ 13.09M $ 5.57M PE Ratio